https://www.selleckchem.com/products/Y-27632.html
Simvastatin is the first line therapeutic drug for coronary heart disease and atherosclerosis. The protective effect mechanism of simvastatin on cardiomyocytes is unclear. This study explores the effect of simvastatin on high glucose induced cardiomyocyte injury and the role of autophagy during the process. H9c2 cells were incubated with different doses of glucose (0, 50, 100, 200 mM) for 24 h to verify the glucose induced injury. The H9c2 cells were pre-treated with simvastatin at different dosages (0, 0.1, 0.5, 1 μM) for 30 min to res
Like
Comment
Share
